Overexpression of GRP78 induces resistance in tumors to various therapeutic drugs, including chemotherapeutic drugs, antihormonal drugs, DNA damaging agents, and anti-angiogenic factors, while the sensitivity of tumor cells to chemotherapy is significantly enhanced after GRP78 inhibition (Chen et al., 2018). Here, HSPA5 is linked to neoplasm.